A
Aptus Pharma Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Aptus Pharma Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹70
Per ShareLot Size
2000 Shares
Minimum Investment
₹1,40,000
Issue Size
₹13.02 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35.11%
QIB Quota
49.83%
NII Quota
15.06%
IPO Timeline
Important dates for your applying strategy.
IPO Opens23 Sept
IPO Closes25 Sept
Basis of Allotment26 Sept
Refund Initiation29 Sept
Shares Credited29 Sept
Aptus Pharma Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
100%
Promoter Holding (Post-Issue)
72.89%
Issue Type
Book Building - SME
ISIN
INE15XJ01010
About the Company
Our Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. We do not own any manufacturing plants but has entered into contract manufacturing agreement with seven manufacturing units. under various arrangements. Of these, we have formal loan and license agreements in place with two manufacturing units. The remaining production is carried out through informal arrangements with Other Manufacturers, based on purchase orders (PO). We provide a diverse range of pharmaceutical products catering to various therapeutic categories including anti-infectives, gastrointestinal, antacids, anti-allergic and respiratory, nutritional supplements, pain management, neuro-psychiatric, cardiovascular, anti-diabetic, lipid-lowering, and general wellness products. These are offered across a variety of dosage forms, such as tablets, capsules, softgels, syrups, suspensions, injections, ointments, creams, balms, drops, lotions, vials, powders, gels, and sachets.
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Standalone figures
Revenue
Amount in ₹ crore
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public issue of up to 18,60,000 equity shares of face value of Rs. 10/- each ("Equity Shares") of Aptus Pharma Limited (the "Company" or "Aptus" or "Issuer") at an issue price of Rs. 70 per equity share (Including a share premium of Rs.60 per equity share) for cash, aggregating up to Rs. 13.02 crores ("Public Issue") out of which 94,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 70 per equity share for cash, aggregating Rs.0.66 crores will be reserved for subscription by the market maker to the issue (the "Market Maker Reservation Portion"). The public issue less market maker reservation portion i.e. issue of 17,66,000 equity shares of face value of Rs. 10/- each, at an issue price of Rs. 70 per equity share for cash, aggregating up to Rs.12.36 crores is hereinafter referred to as the "Net Issue". The public issue and net issue will constitute 27.11 % and 25.74 % respectively of the post-issue paid-up equity share capital of the company. Price Band: Rs. 70/- for equity share of face value of Rs. 10 each. The floor price is 14.00 times times the face value of the face value of the equity shares. Bids can made for a minimum of 4,000 equity shares and in multiples of 2,000 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Diversified Product Portfolio.
- Robust and Responsive Distribution Network.
- Strategic Manufacturing Partnerships.
Frequently Asked Questions
01What is the minimum investment required to apply for this IPO?
The minimum investment depends on the lot size and the upper price band of the issue. Investors must apply for at least one lot, and the total investment amount is calculated by multiplying the lot size by the upper price band.
02How is IPO allotment decided?
IPO allotment is determined based on demand and SEBI guidelines. If the IPO is oversubscribed in the retail category, allotment is typically done through a computerized lottery system to ensure fair distribution among eligible applicants.